Robert D Christensen1, Vickie L Baer2, Erick Henry3, Gregory L Snow4, Allison Butler4, Martha C Sola-Visner5. 1. Divisions of Hematology/Oncology, and Neonatology, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah; Primary Children's Hospital, Salt Lake City, Utah; robert.christensen@hsc.utah.edu. 2. Women and Newborn's Clinical Program, Intermountain Healthcare, Salt Lake City, Utah; 3. Primary Children's Hospital, Salt Lake City, Utah; 4. Statistical Data Center, LDS Hospital, Salt Lake City, Utah; and. 5. Division of Neonatal Medicine, Children's Hospital and Harvard Medical School, Boston, Massachusetts.
Abstract
BACKGROUND: Thrombocytopenia is common among small-for-gestational-age (SGA) neonates (birth weight <10th percentile reference range), but several aspects of this thrombocytopenia are unclear, including the incidence, typical nadir, duration, association with preeclampsia, mechanism, and risk of death. METHODS: Using 9 years of multihospital records, we studied SGA neonates with ≥2 platelet counts <150,000/μL in their first week. RESULTS: We found first-week thrombocytopenia in 31% (905 of 2891) of SGA neonates versus 10% of non-SGA matched controls (P < .0001). Of the 905, 102 had a recognized cause of thrombocytopenia (disseminated intravascular coagulation, early-onset sepsis, or extracorporeal membrane oxygenation). This group had a 65% mortality rate. The remaining 803 did not have an obvious cause for their thrombocytopenia, and we called this "thrombocytopenia of SGA." They had a mortality rate of 2% (P < .0001) and a mean nadir count on day 4 of 93,000/μL (SD 51,580/μL, 10th percentile 50,000/μL, 90th percentile 175,000/μL). By day 14, platelet counts were ≥150,000/μL in more than half of the patients. Severely SGA neonates (<1st percentile) had lower counts and longer thrombocytopenia duration (P < .001). High nucleated red cell counts at birth correlated with low platelets (P < .0001). Platelet transfusions were given to 23%, and counts typically more than tripled. Thrombocytopenia was more associated with SGA status than with the diagnosis of maternal preeclampsia. CONCLUSIONS: SGA neonates with clearly recognized varieties of thrombocytopenia have a high mortality rate. In contrast, thrombocytopenia of SGA is a hyporegenerative condition of moderate severity and 2 weeks' duration and is associated with evidence of intrauterine hypoxia and a low mortality rate.
BACKGROUND:Thrombocytopenia is common among small-for-gestational-age (SGA) neonates (birth weight <10th percentile reference range), but several aspects of this thrombocytopenia are unclear, including the incidence, typical nadir, duration, association with preeclampsia, mechanism, and risk of death. METHODS: Using 9 years of multihospital records, we studied SGA neonates with ≥2 platelet counts <150,000/μL in their first week. RESULTS: We found first-week thrombocytopenia in 31% (905 of 2891) of SGA neonates versus 10% of non-SGA matched controls (P < .0001). Of the 905, 102 had a recognized cause of thrombocytopenia (disseminated intravascular coagulation, early-onset sepsis, or extracorporeal membrane oxygenation). This group had a 65% mortality rate. The remaining 803 did not have an obvious cause for their thrombocytopenia, and we called this "thrombocytopenia of SGA." They had a mortality rate of 2% (P < .0001) and a mean nadir count on day 4 of 93,000/μL (SD 51,580/μL, 10th percentile 50,000/μL, 90th percentile 175,000/μL). By day 14, platelet counts were ≥150,000/μL in more than half of the patients. Severely SGA neonates (<1st percentile) had lower counts and longer thrombocytopenia duration (P < .001). High nucleated red cell counts at birth correlated with low platelets (P < .0001). Platelet transfusions were given to 23%, and counts typically more than tripled. Thrombocytopenia was more associated with SGA status than with the diagnosis of maternal preeclampsia. CONCLUSIONS: SGA neonates with clearly recognized varieties of thrombocytopenia have a high mortality rate. In contrast, thrombocytopenia of SGA is a hyporegenerative condition of moderate severity and 2 weeks' duration and is associated with evidence of intrauterine hypoxia and a low mortality rate.
Authors: Cassandra D Josephson; Leon L Su; Robert D Christensen; Christopher D Hillyer; Marta-Inés Castillejo; Michele R Emory; Yulia Lin; Heather Hume; Kirk Easley; Brandon Poterjoy; Martha Sola-Visner Journal: Pediatrics Date: 2009-01 Impact factor: 7.124
Authors: P Muthukumar; V Venkatesh; A Curley; B C Kahan; L Choo; S Ballard; P Clarke; T Watts; I Roberts; S Stanworth Journal: Transfus Med Date: 2012-06-27 Impact factor: 2.019
Authors: Matthew A Saxonhouse; Lisa M Rimsza; Robert D Christensen; Alan D Hutson; Joseph Stegner; Joyce M Koenig; Martha C Sola Journal: Eur J Haematol Date: 2003-11 Impact factor: 2.997
Authors: Robert D Christensen; Hassan M Yaish; Eyby L Leon; Martha C Sola-Visner; Pankaj B Agrawal Journal: Neonatology Date: 2013-02-22 Impact factor: 4.035
Authors: Mario E Beiner; Michal J Simchen; Eyal Sivan; Angela Chetrit; Jacob Kuint; Eyal Schiff Journal: Am J Perinatol Date: 2003-01 Impact factor: 1.862
Authors: Erick Gerday; Vickie L Baer; Diane K Lambert; David A Paul; Martha C Sola-Visner; Theodore J Pysher; Robert D Christensen Journal: Transfusion Date: 2009-06-23 Impact factor: 3.157
Authors: B C MacQueen; R D Christensen; E Henry; A M Romrell; T J Pysher; S T Bennett; M C Sola-Visner Journal: J Perinatol Date: 2017-04-06 Impact factor: 2.521